Investments
6
Want to inform investors similar to Henglu Asset about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Henglu Asset News
Oct 15, 2021
Chinese early-stage cancer screening solution specialist Creative Biosciences (Guangzhou) Co., Ltd has raised 560 million yuan ($87 million) in its Series D round led by Alibaba. The new round attracted a line-up of new investors including China Renaissance’s sub-fund Huaxing Growth Capital, Costone Capital, Agriculture Bank of China’s ABC International, Shanghai-based Henglu Asset, besides existing […] The post Alibaba leads m funding in biotech firm Creative Biosciences first appeared on FI SENSE.
Henglu Asset Investments
6 Investments
Henglu Asset has made 6 investments. Their latest investment was in X-EPIC as part of their Series B on November 11, 2022.
Henglu Asset Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/26/2022 | Series B | X-EPIC | Yes | 4 | ||
4/27/2022 | Series B | |||||
2/28/2022 | Series A | |||||
10/14/2021 | Series D | |||||
8/7/2021 | Seed VC - II |
Date | 11/26/2022 | 4/27/2022 | 2/28/2022 | 10/14/2021 | 8/7/2021 |
|---|---|---|---|---|---|
Round | Series B | Series B | Series A | Series D | Seed VC - II |
Company | X-EPIC | ||||
Amount | |||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 4 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.